Potential IPO gene therapy company snags $65 million Series C round (Video)
October 13, 2015 at 17:26 PM EDT
Audentes Therapeutics Inc. raised $65 million in a Series C round from new crossover investors and existing venture capital backers, the gene therapy company said Tuesday, setting it up for an IPO as it explores potential one-shot cures for deadly rare diseases...
